Tred, you wrote:
This is all coming out in the wash proving our MOA for Alzheimer’s which is the Big Daddy, all else is window dressing imo.
The one issue I had with Biostock's superlative post was that Missling has stated that he may need to partner with someone for the Asian Rett market. Probably due to regional preferences imo. That is also why I feel yesterdays conference was not just window dressing for Anavex. Rett is most likely first to market for Anavex and announcing a partner may have some significance for the sp. Perhaps it will at least get Anavex's sp to a much higher base point for Missling if he needs to sell some shares at some point and a higher base makes shareholders happier too. The question in my mind is not "if", but when.
Market Data 
Markets 
AI
